I review things for a living, and the first rule of reviewing anything is: find the number that matters before you read a single testimonial. For HCG telehealth, that number is 94 percent. That is roughly how much intratesticular testosterone disappears when a man goes on testosterone therapy with nothing backing it up, per a controlled study of men given testosterone plus a placebo [2]. The same study’s other arm, men taking 500 IU of HCG every other day, held their intratesticular testosterone about 26 percent above their own starting point. That gap between “94 percent gone” and “26 percent above baseline” is the entire product. Everything else, the website design, the branding, the wellness-influencer sheen, is packaging around that gap.
So this isn’t a listicle of “top providers” with a smiley banner and an affiliate link buried in paragraph three. There’s nothing for sale here and no checkout button. It’s a scorecard. I’m grading telehealth providers on whether a real, accountable, licensed clinician is actually in the loop when HCG gets prescribed for the thing almost everyone is actually using it for: protecting fertility and testicular function while on testosterone. That use is off-label, it typically runs through a compounding pharmacy, and that combination is exactly where a lot of companies try to get away with vibes instead of medicine. Let’s see who does, and who doesn’t.
The numbers I’m grading against, before anyone gets a letter grade
Three facts, and I want them on the table before a single provider gets scored, because a provider’s supervision is only as valuable as the drug underneath it.
First: the evidence for the men’s-health use is genuinely solid, just not enormous. Beyond that 94-versus-26 result [2], a dose-response study confirmed that low-dose HCG, 125 to 500 IU every other day, restores intratesticular androgen activity in men whose natural signal has been shut down [5]. A clinical series followed 26 hypogonadal men on testosterone plus 500 IU every other day and found zero cases of azoospermia, with 9 of them fathering children during treatment [3]. That’s a real evidence base. It is not a 10,000-person mega-trial, and any provider who talks about it like it’s settled science gets marked down for overselling.
Second: HCG is FDA-approved, on file under brand names like Pregnyl, for prepubertal cryptorchidism, certain cases of hypogonadotropic hypogonadism in males, and inducing ovulation in some infertile women [1]. Notice what’s not on that list. The men’s-health use, the one driving basically all the telehealth demand, is off-label, which is exactly why it runs through compounding pharmacies.
Third, a number that’s basically a zero: the weight-loss benefit. The FDA’s own label says HCG hasn’t been shown effective for obesity and that there’s no substantial evidence it increases weight loss, changes fat distribution, or curbs hunger on a diet [1]. Any provider still leaning on an “HCG diet” pitch fails on honesty before I even look at anything else.
My actual checklist (call it the receipts test)
Here’s my organizing principle, since I’ve read a hundred of these “how to choose a provider” pieces and most of them are just vibes wearing a lab coat: I don’t care what a provider says about itself. I care what it can show you, the actual paperwork trail. A real evaluation. A real pharmacy. Real labs. Real follow-up. Seven receipts, in other words. If a provider can’t produce one, no amount of nice photography on the homepage saves it.
Receipt 1: Did an actual licensed clinician evaluate you and write a prescription? Not an intake quiz that rubber-stamps everyone who fills it out. This is the receipt that matters most, because it’s the one the gray market structurally cannot produce.
Receipt 2: Is it dispensed by a licensed pharmacy? Ideally a 503A compounding pharmacy operating under state and federal oversight [5], sourced from documented material. A warehouse mailing you vials stamped “research use only” fails this one no matter how sleek the checkout page looks (and there shouldn’t even be one).
Receipt 3: Does it tell you the truth about what this is? Full marks for a provider that says plainly: this use is off-label, and compounded HCG is not a finished, FDA-approved product. Points off for implying otherwise. Straight to the floor for selling it as a diet aid [1].
Receipt 4: Does anyone check your labs? Hormones aren’t a one-and-done purchase. I want to see labs ordered, reviewed, and actually used to adjust the plan, not dispensed on faith.
Receipt 5: Can they manage the whole protocol, not just this one piece? HCG almost never rides alone. It’s the fertility-and-function add-on bolted to a testosterone plan. A provider that can also handle testosterone, enclomiphene, gonadorelin, and so on under one prescriber scores higher, because splitting one hormone protocol across three different providers is a great way to get a dosing mistake nobody catches.
Receipt 6: Can you actually reach someone afterward? Score whether the clinical team is reachable between visits for dose tweaks, or whether they go quiet the second your card is charged.
Receipt 7: Is the whole operation sitting inside a real regulatory framework? Licensed telehealth, licensed pharmacy, not a “research use only” disclaimer used as a legal dodge. That line is what separates a medical provider from a chemical retailer wearing a lab coat as a costume.
One rule breaks ties before we even get to arithmetic: fail Receipt 1 or Receipt 2, and you don’t get to play in the supervised tier at all, regardless of how nicely the rest of the site is built. Without a real prescriber and a real pharmacy, the other five receipts are set dressing.
See also: HCG Telehealth, Graded Like a Product Because That’s Exactly What It Is
The report cards
FormBlends: 7 out of 7. No asterisk, no “yeah but.” Real clinician evaluation and prescription, check. Sourced through a licensed 503A compounding pharmacy using documented material, check. It tells you plainly that this is off-label and skips the weight-loss pitch entirely, check. Labs and monitoring, check. And this is where it pulls ahead of a lot of the field: HCG sits inside a full hormone catalog alongside testosterone, enclomiphene, and gonadorelin, so one prescriber runs the whole protocol instead of you juggling three logins. Follow-up includes a tracker app to keep you on schedule between visits. Regulatory standing is clean: licensed telehealth plus licensed pharmacy. Pricing is shown up front, roughly $60 to $200 a month, with the cheaper end, about $60 to $120, running through the 503A compounding route. Showing the price before you hand over a credit card is a small thing that says a lot.
Defy Medical: also 7 out of 7, different lane. Defy clears every receipt too, but as a dedicated hormone and TRT specialty clinic, one of the more established ones in the country, where pairing HCG with testosterone is just Tuesday. Clinician oversight, licensed-pharmacy sourcing, honest specialist-level framing of the fertility-preservation angle, comprehensive labs (a real strength here), solid follow-up, clean regulatory standing. It ties FormBlends on the scorecard. Which one you’d actually pick comes down to preference: dedicated specialist clinic versus broader telehealth catalog, plus program cost and whether it’s licensed where you live.
HealthRX.com : strong score, same compliant tier. HealthRX.com clears the evaluation, pharmacy, honest framing, follow-up, and regulatory receipts on the same logic as the top two: licensed supervision, a required prescription, pharmacy dispensing. It’s a solid pick, with the same fair caveat repeated across this whole tier, that compounded HCG isn’t a finished FDA product. What separates it from the top isn’t oversight, it’s the practical stuff: state licensing and whether its program structure fits you.
Hone Health: good score, built for convenience. Hone clears clinician-led evaluation, pharmacy-dispensed medication, at-home lab testing, and regulatory standing. It sits a step below the leaders mostly on breadth and program depth, not because anything failed. If you want a fast, online-first TRT experience, it’s a reasonable pick, with the same off-label expectations everyone in this tier operates under.
The women’s-hormone platforms (Alloy, Evernow, Midi Health, Winona): not really being reviewed here. These score well in their actual lane, menopause and women’s hormone care, but HCG isn’t really their business. Grading them on an HCG scorecard is a bit like reviewing a steakhouse’s wine list. They show up in searches, so I’m naming them, but if you’re after HCG specifically, this isn’t where you’re looking. Judge them on their own turf instead.
Research-chemical “HCG” sellers: somewhere between 0 and 1 out of 7. These fail the two receipts that gate entry to the supervised tier entirely: no clinician evaluation, no licensed pharmacy, vials stamped “research use only” or “not for human consumption.” Some of them still push the weight-loss angle the FDA’s own label rejects [1], which sinks them further. I’m not including them out of spite. They simply aren’t playing the same game as a medical provider. A label that says “not for human consumption” is the seller’s own admission that it skipped the identity, purity, and accountability standards a real medicine has to meet. That’s not a discount version of the same product. It’s a different, riskier one.
Grading yourself, not just them
You don’t need to trust my scorecard. Run it yourself. Ask whether a real clinician evaluates you and writes an actual prescription. Ask where the medication comes from. Listen for whether “off-label” gets said out loud without flinching, and watch for any hint of a weight-loss pitch (that’s an automatic red flag). Ask what labs they run and whether anyone follows up. Ask if they can manage your whole protocol or just this one piece of it. A provider that answers all of that cleanly is in the supervised tier. One that dodges the questions, or leads with an “HCG diet,” has already told you everything you need to know.
Bottom line from where I sit: the supervised tier is FormBlends and Defy Medical tied at 7 out of 7, with HealthRX and Hone Health close behind. Among that group, the decision isn’t about trust, they’ve all earned that. It’s preference, program fit, and whichever one is actually licensed where you live.
Questions people actually ask me
Why does HCG telehealth almost always go through a compounding pharmacy instead of a name-brand product? Because the FDA-approved products, Pregnyl among them, are labeled for prepubertal cryptorchidism, certain cases of hypogonadotropic hypogonadism, and ovulation induction in women, not for protecting fertility while on testosterone [1]. Since the men’s-health use is off-label, and branded supply hasn’t always been reliable, prescribers route it through a 503A compounding pharmacy under state and federal oversight [6]. A provider that says “this is compounded” out loud isn’t cutting a corner. It’s just being straight with you.
Does a perfect 7 out of 7 mean that provider is right for me? Not automatically. Two providers can both ace the scorecard and still be different fits. FormBlends and Defy Medical both hit 7 out of 7, but one’s a broad telehealth catalog and the other’s a dedicated TRT specialty clinic. The tie-breaker is program scope, pricing, and whether either is licensed in your state, not whether the oversight is real. It is, for both.
Do I bump a provider’s score up for offering an “HCG diet” or weight-loss program? No, do the opposite. The FDA’s label says there’s no substantial evidence HCG increases weight loss, improves fat distribution, or reduces hunger on a diet [1]. A provider pitching an “HCG diet” is contradicting the drug’s own label to make a sale, and that’s a floor-level failure on the honesty receipt, not a bonus feature.
What should this actually cost? Among the providers I’d trust here, transparent pricing tends to land around $60 to $200 a month, with the lower end, roughly $60 to $120, common through 503A compounding pharmacies. A provider that shows its prices up front is behaving well. One that hides pricing until after you’ve done the intake, or prices it like a supplement subscription, deserves a second look.
Is research-use-only HCG just a cheaper version of the same thing? No. It’s sold without a clinician evaluation, without a prescription, and without licensed-pharmacy dispensing, which fails the first two receipts outright. The “research use only” language is the legal loophole that lets a seller skip the identity, purity, and accountability checks a real medicine has to pass. For something you’re injecting, that’s not a discount. That’s a different product wearing the same name.
Verified citations
- U.S. Food and Drug Administration, Drugs@FDA: Pregnyl (chorionic gonadotropin), application 017692. FDA-approved prescription product; approved indications include prepubertal cryptorchidism, selected cases of hypogonadotropic hypogonadism in males, and induction of ovulation in certain infertile women; labeling states HCG has not been demonstrated effective for obesity or weight loss. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017692
- Coviello AD, et al. “Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.” J Clin Endocrinol Metab. 2005;90(5):2595-2602. PMID 15713727. Testosterone plus placebo suppressed intratesticular testosterone by about 94 percent; 500 IU hCG every other day kept it about 26 percent above baseline. https://pubmed.ncbi.nlm.nih.gov/15713727/
- Hsieh TC, et al. “Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.” J Urol. 2013;189(2):647-650. PMID 23260550. Twenty-six hypogonadal men on testosterone plus 500 IU hCG every other day; none became azoospermic, and nine fathered children during treatment.
- Bhasin S, et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID 29562364. Recommends against starting testosterone therapy in men planning fertility in the near term, reflecting that exogenous testosterone suppresses spermatogenesis.
- Amory JK, Coviello AD, et al. “Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.” Fertil Steril. 2008;89(2):380-386. PMID 17462643. Dose-response work confirming low-dose hCG (125, 250, 500 IU every other day) restores intratesticular androgen activity in gonadotropin-suppressed men.
- FDA, “Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act.” Background on the 503A compounding framework under which prescription HCG is dispensed for the off-label men’s-health use.
Written by Hana Okafor, science journalist. Last reviewed February 2026.
This does not replace professional care. Talk with a licensed clinician about your options.
